首页> 外文OA文献 >General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
【2h】

General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.

机译:全科医生对抗抑郁药耐受性的认识:选择性5-羟色胺再摄取抑制剂与三环抗抑郁药的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: To examine inceptions and discontinuations of antidepressants in general practice. DESIGN: An observational study analysing data from an ongoing cross sectional postal survey. Every three months a representative sample of 250 doctors recorded prescribing activity for four weeks. This provided 4000 general practitioner weeks of recording per year. SETTING: A representative panel of general practitioners in England, Wales, and Scotland. SUBJECTS: Patients who began a new course of an antidepressant or had their treatment stopped or changed by the general practitioner between 1 July 1990 and 30 June 1995. MAIN OUTCOME MEASURES: Numbers of patients prescribed a new course of antidepressant; numbers discontinuing treatment; the ratio of antidepressant discontinuations to antidepressant inceptions; reasons for discontinuation; proportion of switches to another antidepressant. RESULTS: There were 13,619 inceptions and 3934 discontinuations of selective serotonin reuptake inhibitors and tricyclic antidepressants during the study. The number of newly prescribed courses of antidepressants increased by 116%, mostly due to an increase in prescribing of serotonin reuptake inhibitors. The ratio of total discontinuations to inceptions was significantly lower for serotonin reuptake inhibitors (22%) than for tricyclic antidepressants (33%). Differences persisted when controlled for age and sex of patients and severity of depression. However, there was more switching away from selective serotonin reuptake inhibitors when they failed (72%) than from tricyclic antidepressants (58%). CONCLUSIONS: Selective serotonin reuptake inhibitors are less likely than tricyclic antidepressants to be discontinued. A prospective study is needed in general practice to assess the implications of differences in discontinuation rates and switches on clinical and economic outcomes.
机译:目的:研究一般实践中抗抑郁药的起始和停用情况。设计:一项观察性研究,分析正在进行的横断面邮政调查中的数据。每三个月,由250名医生组成的代表样本记录为期4周的处方活动。每年可以提供4000个全科医生的记录周。地点:英格兰,威尔士和苏格兰的全科医生代表小组。研究对象:1990年7月1日至1995年6月30日之间开始新疗程的抗抑郁药治疗或被全科医生停药或更改治疗的患者。主要观察指标:开具新疗程的抗抑郁药的患者人数。终止治疗的人数;抗抑郁药停用与抗抑郁药起始的比率;停产原因;换用另一种抗抑郁药的比例。结果:在研究过程中,选择性5-羟色胺再摄取抑制剂和三环类抗抑郁药的起始时间为13,619次,停药时间为3934次。新开的抗抑郁药疗程数增加了116%,这主要是由于5-羟色胺再摄取抑制剂处方的增加。血清素再摄取抑制剂(22%)的总中断与开始的比率显着低于三环类抗抑郁药(33%)的比率。当控制患者的年龄和性别以及抑郁的严重程度时,差异仍然存在。但是,选择性5-羟色胺再摄取抑制剂在失败时的转换率要高于三环类抗抑郁药的转换率(58%)(72%)。结论:选择性5-羟色胺再摄取抑制剂停药的可能性低于三环类抗抑郁药。在一般实践中,需要进行前瞻性研究,以评估停药率差异以及转换对临床和经济结果的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号